Patent · US Active

Pharmaceutical compositions

US10668018B2 · kind B2 · utility

7Cited by

9References

21Claims

0Family size

Assignee

Mexichem Amanco Holdings S.A. de C.V. · MX

Inventors

Stuart Corr · Appleton, GB
Timothy James Noakes · Winchester, GB

Key dates

Filing date	Jan 16, 2019
Grant date	Jun 2, 2020
Priority date	—
Expiry date	Jan 16, 2039

Classification

Technology area (CPC A)Human Necessities
CPC primaryA61P11/06
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

A pharmaceutical solution for a medication delivery apparatus, especially a metered dose inhaler, is described. The pharmaceutical solution comprises: (a) a liquefied propellant component consisting essentially of and preferably consisting entirely of 1,1-difluoroethane (R-152a); (b) ethanol; and (c) a drug component dissolved in the propellant/ethanol mixture consisting of at least one drug selected from the group consisting of beclomethasone dipropionate (BDP) and fluticasone propionate (FP).

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.